| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8267390 | Free Radical Biology and Medicine | 2016 | 7 Pages |
Abstract
Serum R-SH are associated with a beneficial cardiovascular risk profile and better patient and graft survival in RTR, suggesting potential usefulness as low-cost, high-throughput screening tool for whole-body redox status in translational studies. Whether R-SH modification improves long-term outcome of RTR warrants further exploration.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Anne-Roos S. Frenay, Martin H. de Borst, Matthias Bachtler, Nadine Tschopp, Charlotte A. Keyzer, Else van den Berg, Stephan J.L. Bakker, Martin Feelisch, Andreas Pasch, Harry van Goor,